Article

Ophthalmology companies rank in Fortune's top 100

Two companies from the ophthalmology industry appeared on Fortune Magazine's list of the "100 Best Companies to Work For in 2008."

New York-Two companies from the ophthalmology industry appeared on Fortune Magazine's list of the "100 Best Companies to Work For in 2008." Genentech came in at number five and Alcon Laboratories at number 60.

At Genentech there are 10,842 employees in the United States. Its most common salaried job is research associate with an average annual pay of $85,880. The South San Francisco company offers 160 hours of professional training to its employees, paid sabbaticals, on-site child care, 100% health care coverage, and an on-site fitness center.

It also tops the charts in diversity with 44% of its employees being minorities and 50% women. Same-sex couples are offered domestic partner benefits and a nondiscrimination policy that includes sexual orientation.

If a Genentech employee goes to work by bicycle, foot, via public transportation, or in a carpool a subsidy of $4 a day is granted.

Alcon is smaller with about half of its employees outside of the United States. Job growth is 6% per year and the most common salaried job pays on average $94,469 per year. Its U.S. headquarters is based in Fort Worth, TX.

Employees of Alcon receive 212 hours of training and have access to an on-site gym. Alcon may offer one of the richest retirement programs in U.S. business with employee contributions matched 2.2 to one.

Diversity is lower with 27% minorities and 47% women. A nondiscrimination policy is in place.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.